Excelsior Correspondent
JAMMU, Mar 19: Patanjali’s research paper on the herbal formulation Renogrit has been recognized among the top 100 research papers of 2024 in the prestigious Scientific Reports journal, part of the globally renowned Nature Portfolio publication.
With an Impact Factor of 3.8, Scientific Reports ranks as the fifth most-cited journal worldwide.
Speaking on the occasion, Acharya Balkrishna, who was also part of the research team, said, “The success of Renogrit is a significant step in establishing the scientific credibility of Ayurveda on a global scale. It demonstrates that when ancient wisdom is tested on modern scientific parameters, it yields groundbreaking results.”
The study on Renogrit has already been downloaded 2,568 times, highlighting the increasing global interest in Ayurvedic medicines as not only effective therapeutic solutions but also as a subject of scientific exploration.
The research underscores how a simple herbal formulation can combat severe diseases without adverse side effects, reinforcing Ayurveda’s scientific credibility on an international scale.
Patanjali’s Ayurvedic formulation, Renogrit, has demonstrated its potential not only in repairing kidney damage caused by the allopathic anti-cancer drug, cisplatin, but also in alleviating oxidative stress on kidney cells.
This groundbreaking discovery paves the way for integrating Ayurvedic medicine with modern therapeutic approaches to enhance patient outcomes.
Follow our WhatsApp channel
